Inflammation Global Clinical Trials Review, H2, 2013

  • September 2013
  • -
  • Global Data
  • -
  • 110 pages

Inflammation Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Inflammation Global Clinical Trials Review, H2, 2013" provides data on the Inflammation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inflammation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Inflammation 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Inflammation 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Inflammation Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novo Nordisk A/S 35
Clinical Trial Overview of Novo Nordisk A/S 35
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Bausch and Lomb Incorporated 38
Clinical Trial Overview of Bausch and Lomb Incorporated 38
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Sirion Therapeutics, Inc. 41
Clinical Trial Overview of Sirion Therapeutics, Inc. 41
Allergan, Inc. 42
Clinical Trial Overview of Allergan, Inc. 42
Perrigo Company 43
Clinical Trial Overview of Perrigo Company 43
Sandoz Inc. 44
Clinical Trial Overview of Sandoz Inc. 44
Galapagos NV 45
Clinical Trial Overview of Galapagos NV 45
Infinity Pharmaceuticals, Inc. 46
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 46
Amgen Inc. 47
Clinical Trial Overview of Amgen Inc. 47
Celgene Corporation 48
Clinical Trial Overview of Celgene Corporation 48
SIFI S.p.A 49
Clinical Trial Overview of SIFI S.p.A 49
X-pert Med GmbH 50
Clinical Trial Overview of X-pert Med GmbH 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Merck and Co., Inc. 52
Clinical Trial Overview of Merck and Co., Inc. 52
Takeda Pharmaceutical Company Limited 53
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 53
Clinical Trial Overview of Top Institutes / Government 54
National Heart, Lung, and Blood Institute 54
Clinical Trial Overview of National Heart, Lung, and Blood Institute 54
Radboud University 56
Clinical Trial Overview of Radboud University 56
Vanderbilt University 57
Clinical Trial Overview of Vanderbilt University 57
Maastricht University Medical Center 58
Clinical Trial Overview of Maastricht University Medical Center 58
University of Cincinnati 59
Clinical Trial Overview of University of Cincinnati 59
Emory University 60
Clinical Trial Overview of Emory University 60
The National Institute of Allergy and Infectious Diseases 61
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 61
University of California, Davis 62
Clinical Trial Overview of University of California, Davis 62
Assistance Publique - Hopitaux de Paris 63
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 63
University of California, San Francisco 64
Clinical Trial Overview of University of California, San Francisco 64
U.S. Department of Veterans Affairs 65
Clinical Trial Overview of U.S. Department of Veterans Affairs 65
Massachusetts General Hospital 66
Clinical Trial Overview of Massachusetts General Hospital 66
Stanford University 67
Clinical Trial Overview of Stanford University 67
Leiden University Medical Center 68
Clinical Trial Overview of Leiden University Medical Center 68
The Ohio State University 69
Clinical Trial Overview of The Ohio State University 69
Medical University of Vienna 70
Clinical Trial Overview of Medical University of Vienna 70
Assaf-Harofeh Medical Center 71
Clinical Trial Overview of Assaf-Harofeh Medical Center 71
The University of Edinburgh 72
Clinical Trial Overview of The University of Edinburgh 72
Aarhus University 73
Clinical Trial Overview of Aarhus University 73
Brigham and Women's Hospital 74
Clinical Trial Overview of Brigham and Women's Hospital 74
Five Key Clinical profiles 75
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 109

List of Tables
Inflammation Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Inflammation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Inflammation Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Inflammation Therapeutics Clinical Trials, G7 Countries, 2013* 17
Inflammation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Inflammation Therapeutics Clinical Trials, E7 Countries, 2013* 19
Inflammation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Inflammation Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Inflammation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Inflammation Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Inflammation Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Inflammation Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Inflammation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2013* 35
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 37
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch and Lomb Incorporated, 2013* 38
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 39
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 40
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirion Therapeutics, Inc., 2013* 41
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 42
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Perrigo Company, 2013* 43
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz Inc., 2013* 44
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Galapagos NV, 2013* 45
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2013* 46
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 47
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2013* 48
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by SIFI S.p.A, 2013* 49
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by X-pert Med GmbH, 2013* 50
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 51
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2013* 52
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 53
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 54
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013* 56
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 57
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2013* 58
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2013* 59
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 60
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 61
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2013* 62
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 63
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 64
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 65
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 66
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 67
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 68
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2013* 69
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 70
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2013* 71
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2013* 72
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2013* 73
Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 74

List of Figures
Inflammation Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Inflammation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Inflammation Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Inflammation Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Inflammation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Inflammation Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Inflammation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Inflammation Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Inflammation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Inflammation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
GlobalData Methodology 107

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Enabling Technological Platforms for Lab-on-Chip Applications  (Technical Insights)

Enabling Technological Platforms for Lab-on-Chip Applications (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

6 Dimensional Assessment of Lab on a Chip Innovation Landscape A growing trend towards miniaturizing laboratory practices has been a major driving force behind the steady increase of innovations in the ...

Global Proteomics Market

Global Proteomics Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of ...

Biologicals in Oncology Drug Pipeline Update 2014

Biologicals in Oncology Drug Pipeline Update 2014

  • $ 3 749
  • Industry report
  • July 2014
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 908 companies plus partners developing 1686 biological ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.